Biofrontera Inc. (BFRI)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$1.55
+5.14%
Mkt Cap $19.85M
No analyst coverage available
We don't have analyst ratings or price target data for Biofrontera Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.